← Back to Search

Social Media Messages for Colorectal Cancer Screening

N/A
Waitlist Available
Led By Nancy N. Baxter, MD, FRCSC, FACS, PhD
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Facebook users in Ontario who are between 55-64 years of ag
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the end of the study period at 1 month
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether social media messages about colorectal cancer screening can increase people's intention to get screened for the disease. The results could be used to help other cancer screening programs reach more people effectively.

Who is the study for?
This trial is for Facebook users in Ontario who are over the age of 50. It's designed to see if certain social media messages can encourage people to get screened for colorectal cancer.
What is being tested?
The study is testing different social media messages about colorectal cancer screening. Participants will be randomly assigned to receive one of several tailored messages, and researchers will track if these lead to increased screening intentions.
What are the potential side effects?
Since this trial involves receiving information through social media, there are no direct medical side effects. However, participants may experience an increase in awareness or anxiety about colorectal cancer screening.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the end of the study period at 1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the end of the study period at 1 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Screening intention
Secondary study objectives
Click-through-rate
Cost-per-click
Number of impressions
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

6Treatment groups
Active Control
Group I: Arm #4Active Control1 Intervention
This arm will receive the fourth social media message that is preferred by our target population as identified from our previous focus group study.
Group II: Control ArmActive Control1 Intervention
This arm will not receive any intervention.
Group III: Message #3Active Control1 Intervention
This arm will receive the third social media message that is preferred by our target population as identified from our previous focus group study.
Group IV: Tailored ArmActive Control1 Intervention
This arm will receive social media messages that will be tailored by sex.
Group V: Message #1Active Control1 Intervention
This arm will receive one of five social media messages that is preferred by our target population through focus groups that are being conducted as part of a previous study.
Group VI: Message #2Active Control1 Intervention
This arm will receive the second social media message that is preferred by our target population as identified from our previous focus group study.

Find a Location

Who is running the clinical trial?

Unity Health TorontoLead Sponsor
556 Previous Clinical Trials
398,406 Total Patients Enrolled
Applied Health Research CentreOTHER
22 Previous Clinical Trials
14,896 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,388 Previous Clinical Trials
26,462,073 Total Patients Enrolled
~0 spots leftby Nov 2024